Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

Zhejiang Jiuzhou Pharmaceutical Co. Ltd. | Ownership

Companies that own Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Baoying Fund Management Co., Ltd.
1,934,280
0.24%
-12,739,799
0.07%
12/31/2017
The Vanguard Group, Inc.
731,570
0.09%
0
0%
07/31/2018
China Southern Asset Management Co., Ltd.
702,697
0.09%
-3,258,301
0.01%
12/31/2017
GF Fund Management Co., Ltd.
195,120
0.02%
195,120
0%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
52,560
0.01%
29,700
0.01%
12/31/2017
Lion Fund Management Co., Ltd.
52,020
0.01%
52,020
0%
12/31/2017
Da Cheng Fund Management Co., Ltd.
180
0%
0
0%
12/31/2017
China Merchants Fund Management Co., Ltd.
0
0%
-358,873
0%
06/30/2017
Hwabao WP Fund Management Co., Ltd.
0
0%
-5,940
0%
12/31/2017
Bank of China Investment Management Co., Ltd.
0
0%
-98,640
0%
12/31/2017

About Zhejiang Jiuzhou Pharmaceutical Co.

View Profile
Address
99 Waisha Road
Taizhou Zhejiang 318000
China
Employees -
Website http://www.jiuzhoupharma.com
Updated 07/08/2019
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. Its products include Carbamazepine, Oxcarbazepine, Duloxetine, Amprolium, Sulphadimethoxine, Sulphadimethoxine Sodium, Sulfasalazine, Bezafibrate, Ketoprofen, Gliclazide, Imipenem, Meropenem, Duloxetine and Pregabalin. The company was founded by Xuan De Hua in 1973 and is headquartered in Taizhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.